Technology area: Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Prellis Biologics Inc. currently has 2 pending office actions within the Chemistry & Materials technology area. These actions are assigned to 2 distinct examiners, ensuring that each case is reviewed by a different individual. Furthermore, the actions are located in 2 distinct art units, showing a complete lack of administrative overlap for the company's current cases. AHMED ALI, MOHAMED K is the busiest examiner, responsible for 1 busiest examiner pending action.
The distribution of 2 pending office actions across 2 distinct examiners and 2 distinct art units is notable. No two actions share an examiner or an art unit, which may lead to different prosecution outcomes and timelines even within the same technology area. AHMED ALI, MOHAMED K's status as the busiest examiner is shared with the other distinct examiner, as each has exactly 1 action. This profile suggests that Prellis Biologics Inc. is navigating two entirely separate paths within the Chemistry & Materials area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AHMED ALI, MOHAMED K | 1 | 70.9% | +26.6% |
| WOLLSCHLAGER, JEFFREY MICHAEL | 1 | 62.1% | +29.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18871132 | METHODS AND SYSTEMS FOR THREE-DIMENSIONAL PRINTING | AHMED ALI, MOHAMED K | — |
| 17703162 | THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES | WOLLSCHLAGER, JEFFREY MICHAEL | — |
| Art Unit | Apps |
|---|---|
| 1743 | 1 |
| 1742 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18871132 | METHODS AND SYSTEMS FOR THREE-DIMENSIONAL PRINTING | AHMED ALI, MOHAMED K | 1743 | §103 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 17703162 | THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES | WOLLSCHLAGER, JEFFREY MICHAEL | 1742 | §103 | Non-Final OA | — | Pending | Mar 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPrellis Biologics Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Mohamed K Ahmed Ali has the most, with 1 of Prellis Biologics Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
